Iktos

Categories: Research, Automation / Agents, Healthcare | Pricing: Enterprise | Official Website ↗

Iktos develops generative AI and robotics solutions to accelerate drug discovery, from molecular design to automated synthesis and testing.

Iktos pioneers the integration of generative AI and robotics to transform drug discovery. Its platform combines AI-driven molecular design with automated synthesis and testing, aiming to create fully autonomous labs. This approach is designed to accelerate the development of new treatments and improve patient care by shortening the discovery phase. The core of Iktos's offering includes Makya, a generative AI platform for de novo drug design, and Spaya, an AI-driven retrosynthesis platform. Makya creates diverse, novel, and synthetically accessible molecules, optimized for various project objectives. Spaya identifies feasible synthetic routes, converting target compounds into commercially available starting materials, and is compatible with robotic systems. Iktos Robotics then manages the complete synthetic process, from raw material ordering to chemical synthesis and analysis, integrating with biological data for continuous optimization of molecular properties.

Key Features

Generative AI for de novo drug design (Makya)
AI-driven retrosynthesis planning (Spaya)
Automated chemical synthesis and analysis (Iktos Robotics Chemistry)
AI-guided biological data integration for molecular optimization (Iktos Robotics Biology)
Multi-parametric optimization for compound design
Focus on synthetic accessibility
Real-time display of retrosynthetic routes
High-throughput data generation and iteration

Pros

Integrates generative AI with robotics for end-to-end drug discovery
Accelerates the drug discovery phase to under 2 years
Designs synthetically accessible and optimized molecules
Automates synthesis, purification, analysis, and testing
Continuously optimizes molecular properties using multidimensional biological data

Cons

No public pricing information available
Primarily targets large pharmaceutical and biotech companies
Requires significant integration for full autonomous lab setup
Specific details on data providers for Spaya are not listed
Limited information on direct user control over robotic systems

Use Cases

De novo drug design
Optimizing lead compounds
Identifying feasible synthetic routes
Automated chemical synthesis
High-throughput screening and analysis
Target identification and preclinical candidate development

Best For

Pharmaceutical companies
Biotech institutions
Academic research institutions
Drug discovery teams

Integrations: Chemspeed

Platforms: Web

Watch demo on YouTube ↗

View full Iktos profile on Tools-Radar | Browse Research tools | Alternatives to Iktos

Tools-Radar is a free directory of 10,000+ AI tools — discover, compare, and choose the right AI software for your needs. Visit tools-radar.com